{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:18:43Z","timestamp":1771010323679,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1577,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,10]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Transtympanic gentamicin is becoming increasingly popular in the treatment of Meniere's disease. In this report we examine our experience with the use of microdose gentamicin via the Round Window Microcatheter for the treatment of Meniere's disease. Thirty\u2010six patients were treated with gentamicin administration via the Round Window Microcatheter between July 1997 and August 2000. The patients all underwent 10 days of continuous treatment with a total dose of 2.4\u20133.75 mg of gentamicin (10 mg\/ml). All patients had extensive pre\u2010, intra\u2010, and post\u2010therapy auditory and vestibular testing. In this group, vertigo was eliminated in 89% of the patients, and tinnitus and pressure were significantly reduced in over 60% of the patients. Only one patient suffered a significant hearing loss and, most importantly, in all but one patient vestibular function was improved or normalized after treatment. Round Window Microcatheter\u2010administered microdose gentamicin is an exciting new treatment for Meniere's disease. Preliminary results indicate that vertigo can be controlled without a significant reduction in cochlear or vestibular function in most patients. These results suggest that this therapy may be acting at a non\u2010hair cell site. Our results are compared to the published literature examining transtympanic injection. In addition, the underlying science supporting this type of treatment is examined.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03734.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T23:31:27Z","timestamp":1279668687000},"page":"46-51","source":"Crossref","is-referenced-by-count":26,"title":["Microdose Gentamicin Administration via the Round Window Microcatheter"],"prefix":"10.1111","volume":"942","author":[{"given":"MICHAEL E.","family":"HOFFER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RICHARD D.","family":"KOPKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PETER","family":"WEISSKOPF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIM","family":"GOTTSHALL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEITH","family":"ALLEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DERIN","family":"WESTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"83","article-title":"Middle ear ototoxic treatment for inner ear disease","volume":"457","author":"Odkvist L.M.","year":"1989","journal-title":"Acta Otolaryngol. Suppl."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199701000-00012"},{"key":"e_1_2_6_4_2","first-page":"278","article-title":"Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease: update of an ongoing study","volume":"14","author":"Nedzelski J.M.","year":"1993","journal-title":"Am. J. Otol."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199701000-00017"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199810000-00005"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0030-6665(20)30156-0","article-title":"Use of sustained release vehicles in the treatment of Meniere's disease","volume":"30","author":"Hoffer M.E.","year":"1997","journal-title":"Otolaryngol.Clin. North Am."},{"key":"e_1_2_6_8_2","first-page":"141","article-title":"Round\u2010Window Microcatheter\u2010administered microdose gentamicin: results from treatment of tinnitus associated with Meniere's disease","volume":"4","author":"DeCicco M.J.","year":"1998","journal-title":"Int. Tinnitus J."},{"key":"e_1_2_6_9_2","first-page":"18","article-title":"Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease","volume":"13","author":"Nedzelski J.M.","year":"1992","journal-title":"Am. J. Otol."},{"key":"e_1_2_6_10_2","first-page":"209","article-title":"Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy","volume":"20","author":"Minor L.B.","year":"1999","journal-title":"Am. J. Otol."},{"key":"e_1_2_6_11_2","first-page":"44","article-title":"Intratympanic gentamicin therapy for Meniere's disease","volume":"18","author":"Hirsch B.E.","year":"1997","journal-title":"Am. J. Otol."},{"key":"e_1_2_6_12_2","first-page":"361","article-title":"Treatment of intractable Meniere's disease with intratympanic gentamicin: review of the University of Ottawa experience","volume":"26","author":"Corsten M.","year":"1997","journal-title":"J. Otolaryngol."},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/019459989411000204"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.35.36"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199307000-00007"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0709(85)80013-2"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03734.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03734.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:29:22Z","timestamp":1695641362000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03734.x"}},"subtitle":["Results in Patients with Meniere's Disease"],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03734.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03734.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}